Malaria in Strasbourg University Hospital (ACMUS)

September 13, 2018 updated by: University Hospital, Strasbourg, France

Retrospective Clinical Study of Malaria in Strasbourg University

The primary purpose is to describe the anamnestic, clinical, biological, and therapeutic characteristics of imported malaria in people originated from endemic areas. Indeed, clinicians have observed that people from such areas start malaria just after their arrival in France. Such observation needed to be confirmed. In addition, The investigators observed a variation in the laboratory diagnostic performance of malaria between hospital and private laboratories. Such observation also needed to be analyzed objectively

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service de Maladies infectieuses et tropicales
        • Contact:
        • Sub-Investigator:
          • Anne DINDOYAL, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

iagnosis patients with malaria from 01/01/2017 to 01/01/2018

Description

Inclusion Criteria:- Patient over 18 years

  • Patients from birth to 18 years
  • Patient submitted to guardianship
  • Patient submitted to trusteeship
  • Diagnosis patients with malaria from 01/01/2017 to 01/01/2018
  • Patient or legal representative agree to use medical data for this research

Exclusion Criteria:

  • Lack of confirmation malaria diagnosis
  • Impossibility to inform patients
  • Patient who does not wish to participate in the study
  • Patient submitted to justice safeguarding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Study of clinical characteristics of imported malaria in people originated from endemic areas hospitalized at Strasbourg University Hospital from 2017 to 2018.
Time Frame: The period from January 1st, 2017 to January 1st, 2018 will be examined
The period from January 1st, 2017 to January 1st, 2018 will be examined

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2018

Primary Completion (ANTICIPATED)

August 1, 2019

Study Completion (ANTICIPATED)

August 1, 2019

Study Registration Dates

First Submitted

July 10, 2018

First Submitted That Met QC Criteria

July 10, 2018

First Posted (ACTUAL)

July 20, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 17, 2018

Last Update Submitted That Met QC Criteria

September 13, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 7084

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malaria

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe